Related Experiment Video
Updated: Jul 11, 2026
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Airway clearance applications in infants and children
1Department of Pediatrics, Emory University School of Medicine, Emory Children's Center, 2015 Uppergate Drive, Suite 326, Atlanta, GA 30322-0001. michael.schechter@emory.edu
Insights
Airway clearance therapy offers proven benefits for pediatric cystic fibrosis and is likely helpful for neuromuscular diseases. However, evidence is limited, and it shows minimal benefit for acute asthma or bronchiolitis.
Area of Science:
- Pediatric Pulmonology
- Respiratory Care
- Clinical Evidence Review
Background:
- Airway clearance therapy (ACT) principles are similar for children and adults, but pediatric physiology and pathology present unique challenges.
- A significant limitation in pediatric ACT research is the scarcity of well-designed, adequately powered clinical trials.
- Meta-analyses offer some alleviation to the data deficit in pediatric ACT efficacy.
Purpose of the Study:
- To review the current evidence regarding the efficacy of airway clearance therapy in pediatric populations.
- To identify specific pediatric conditions where ACT is beneficial, potentially harmful, or lacks sufficient evidence.
- To guide clinical practice and highlight areas for future research in pediatric airway clearance.
Main Methods:
- Systematic review of existing pediatric studies on airway clearance therapy.
- Analysis of published meta-analyses to consolidate evidence.
- Evaluation of ACT efficacy across various pediatric respiratory conditions.
Main Results:
- ACT is clearly beneficial for cystic fibrosis in children, with adherence-focused techniques preferred over specific methods.
- ACT is likely beneficial for children with neuromuscular disease and cerebral palsy, and possibly for atelectasis during mechanical ventilation.
- ACT shows minimal to no benefit for acute asthma, bronchiolitis, hyaline membrane disease, PICU respiratory failure, or post-operative atelectasis prevention.
Conclusions:
- Airway clearance therapy is a proven benefit for pediatric cystic fibrosis and likely beneficial for other specific conditions.
- Current evidence is limited, and conclusions may evolve with future high-quality clinical trials.
- Individualized treatment selection prioritizing patient adherence is crucial for effective pediatric airway clearance.
Abstract:
The rationale for airway clearance therapy and basic principles of its application are identical for children and adults, but there are important differences in physiology (regarding airway mucus characteristics and airway mechanics) and pathological processes in children, as well as other considerations unique to the pediatric population. The major obstacle in reviewing the evidence for efficacy of airway clearance therapy in pediatrics is the lack of data from well-performed, adequately powered clinical trials. This problem is partially alleviated by the use of published meta-analyses. A review of pediatric studies suggests that airway clearance therapy is of clear and proven benefit in the routine care of cystic fibrosis, and that no specific airway-clearance technique is clearly superior, but for any individual patient the technique that is most likely to maximize patient adherence to treatment is preferred. Airway clearance therapy appears likely to be of benefit in the routine care of children with neuromuscular disease and cerebral palsy, and is probably of benefit in treating atelectasis in children on mechanical ventilation. Airway clearance therapy may be of benefit in preventing post-extubation atelectasis in neonates. Airway clearance therapy appears to be of minimal to no benefit in the treatment of children with acute asthma, bronchiolitis, hyaline membrane disease, and those on mechanical ventilation for respiratory failure in the pediatric intensive care unit, and it is not effective in preventing atelectasis in children immediately following surgery. All in all, however, given that these conclusions are based on very little data, future well-performed clinical trials might change the weight of evidence to contradict these current conclusions.
Related Concept Videos
01:22Cardiopulmonary Resuscitation II: ACLS Airway Management
01:30Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
01:30Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
01:25Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
01:29Suctioning the Nasopharyngeal Airway
Equipment Required
01:05Breathing